Publication
Angiogenesis inhibitory drug combination obtained according to a specific algorithm, preferably a FSC, in which an initial combination of drugs is iteratively adjusted. The drug combination according to the invention may advantageously comprise a RAPTA-C compound. In a more specific case the combination comprises RAPTA-C and eriotinib.
Nikolaos Geroliminis, Claudia Bongiovanni, Mor Kaspi
Philippe Schwaller, Junwu Chen